Angiogenesis
New angiogenesis findings from University of Munich described
Published in OBGYN and Reproduction Week, January 25th, 2010
"Indications for this extract range from dementia to peripheral vascular disease, based on well-documented vascular effects. Surprisingly, the actions of EGb ® 761 on angiogenesis as a function of vascular cells have not been investigated to date. The anti-cancer activity of EGb ® 761 in vitro and epidemiological data showing reduced risk for ovarian cancer in regular users have prompted us to investigate this issue. We show an anti-angiogenic profile...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Angiogenesis
Study data from Hokkaido University, Medical Department update knowledge of angiogenesis - Apoptosis
Recent findings in apoptosis described by investigators from National Research Council - Bacterial Vaginosis
Researchers from University of North Carolina provide details of new studies and findings in the area of bacterial vaginosis - Breast Cancer Screening
Scientists at Monash University discuss research in breast cancer screening - Chronic Lymphocytic Leukemia
Research from National Institutes of Health provide new insights into chronic lymphocytic leukemia - Cytokines
Studies from Medical University of Vienna yield new information about cytokines - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
